"Mastocytosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Descriptor ID |
D008415
|
| MeSH Number(s) |
C04.557.450.565.465 C17.800.508 C20.543.520.350
|
| Concept/Terms |
Mastocytosis- Mastocytosis
- Mastocytoses
- Mast Cell Activation Syndrome
- Mast Cell Activation Disease
- Mast Cell Activation Syndromes
- Mast Cell Disease
- Mast Cell Diseases
- Mast-Cell Disease
- Mast-Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Mastocytosis".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis".
This graph shows the total number of publications written about "Mastocytosis" by people in this website by year, and whether "Mastocytosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mastocytosis" by people in Profiles.
-
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future. Cancer Res. 2017 03 15; 77(6):1261-1270.
-
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biol Blood Marrow Transplant. 2016 08; 22(8):1348-1356.
-
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
-
Performing colonic mast cell counts in patients with chronic diarrhea of unknown etiology has limited diagnostic use. Arch Pathol Lab Med. 2015 Feb; 139(2):225-32.
-
Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis. Clin Exp Dermatol. 2013 Jul; 38(5):538-44.
-
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells. Leuk Lymphoma. 2008 Aug; 49(8):1567-77.
-
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19977-82.
-
Aggressive systemic mastocytosis presenting with hepatic cholestasis. Eur J Gastroenterol Hepatol. 2007 Oct; 19(10):901-5.
-
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007 Jun; 37(6):435-53.
-
The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol. 2006 Mar; 59(3):298-302.